{"url_path":"/sec/entx/8-k/2026-07-16/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1638097/0001178913-26-003510-index.html","accession_number":"0001178913-26-003510","cik":"0001638097","ticker":"ENTX","issuer_name":"Entera Bio Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1638097/0001178913-26-003510-index.html","primary_entity_key":"0001638097","primary_entity_name":"Entera Bio Ltd."},"word_count":96,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n \n\n \n\n(d)\n\nExhibits\n\n \n\nExhibit\n\nNo\n\n \n\nDescription\n\n[3.1](exhibit_3-1.htm)\n\n[Amended\nand Restated Articles of Association](exhibit_3-1.htm)\n\n[10.1*](exhibit_10-1.htm)\n\n[Amendment\n\nto 2018 Entera Bio Ltd. Equity Incentive Plan](exhibit_10-1.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n* Management contract or compensatory plan or arrangement.\n\nSIGNATURES\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be\nsigned on its behalf by the undersigned hereunto duly authorized.\n\n \n\nENTERA BIO LTD.\n\n \n\n \n\n \n\nDate: July 16, 2026\n\nBy:\n\n/s/ Miranda Toledano\n\n \n\n \n\nName: Miranda Toledano\n\nTitle: Chief Executive Officer"}